Combination of polychitosamine and HMG-CoA reductase inhibitor for hyperlipidemia

Details for Australian Patent Application No. 2005284565 (hide)

International Classifications

Event Publications

19 April 2007 PCT application entered the National Phase

PCT publication WO2006/029524 Priority application(s): WO2006/029524

26 April 2007 Assignment before Grant

Magistral Biotech Inc., Has no value - Entry Incomplete The application has been assigned to DNP Canada Inc.

9 October 2008 Amendment Made

The nature of the amendment is: Add the co-inventor name to read Huc, Jean-Francois 2006

7 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.